Blackstone Inc. (BX) is a giant in the real estate market. We doubt that’s breaking news to most. The company, which currently has a market cap of $173 billion, is the owner of BREIT, its real estate ...

Biotech investors hunting for explosive growth may want to look closely at two emerging innovators making significant progress in high-impact therapeutic areas. Kyverna Therapeutics (KYTX) is ...

Growth stocks, especially in the biotech sector, often have the potential to deliver outsized returns. A breakthrough in clinical trials or regulatory approvals can rapidly transform a biotech stock.

Growth stocks are shares of companies that are still in the process of growing. They allow investors with a high risk tolerance and a longer investment horizon to earn significant returns when the ...

These companies have exceptional dividend track records. AbbVie is moving on from its Humira patent losses, and its portfolio benefits from some exceptionally profitable products. Johnson & Johnson is ...